{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:14:25Z","timestamp":1774962865036,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.mehy.2012.01.035","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T11:45:54Z","timestamp":1329133554000},"page":"594-600","source":"Crossref","is-referenced-by-count":34,"title":["Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia"],"prefix":"10.1016","volume":"78","author":[{"given":"Merouane","family":"Bencherif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal K.","family":"Stachowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron J.","family":"Kucinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Lippiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2012.01.035_b0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0269881106073126","article-title":"Glutamate and dopamine dysregulation in schizophrenia\u2013a synthesis and selective review","volume":"21","author":"Stone","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.mehy.2012.01.035_b0010","article-title":"Treating schizophrenia: novel targets for the cholinergic system","author":"Money","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.mehy.2012.01.035_b0015","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(00)02710-0","article-title":"Dopamine and schizophrenia\u2013proof at last?","volume":"356","author":"Harrison","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2012.01.035_b0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0149-7634(03)00035-6","article-title":"Schizophrenia: from phenomenology to neurobiology","volume":"27","author":"Wong","year":"2003","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.mehy.2012.01.035_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02990472","article-title":"Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders","volume":"14","author":"Kugaya","year":"2000","journal-title":"Ann Nucl Med"},{"issue":"Suppl 1 Pt A","key":"10.1016\/j.mehy.2012.01.035_b0030","doi-asserted-by":"crossref","first-page":"112A","DOI":"10.1097\/00002826-199201001-00061","article-title":"A volumetric MRI study of limbic structures in chronic schizophrenia\u2013relationship to psychopathology","volume":"15","author":"Bogerts","year":"1992","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.mehy.2012.01.035_b0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0361-9230(99)00243-9","article-title":"Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia","volume":"52","author":"Lewis","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.mehy.2012.01.035_b0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03033576","article-title":"Developing translational animal models for symptoms of schizophrenia or bipolar mania","volume":"14","author":"Geyer","year":"2008","journal-title":"Neurotox Res"},{"key":"10.1016\/j.mehy.2012.01.035_b0045","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.0409766102","article-title":"Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis","volume":"102","author":"Seeman","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2012.01.035_b0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0055","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2004.01.027","article-title":"A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book","volume":"55","author":"Mishara","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0060","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(03)00757-8","article-title":"Bringing order to the glutamate chaos in schizophrenia","volume":"40","author":"Moghaddam","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2012.01.035_b0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1523\/JNEUROSCI.16-01-00373.1996","article-title":"NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine","volume":"16","author":"Verma","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1005224610354","article-title":"Neurophysiological correlates of delayed visual differentiation tasks in monkeys: the effects of the site of intracortical blockade of NMDA receptors","volume":"31","author":"Dudkin","year":"2001","journal-title":"Neurosci Behav Physiol"},{"key":"10.1016\/j.mehy.2012.01.035_b0075","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bcp.2004.07.034","article-title":"The GABA-glutamate connection in schizophrenia: which is the proximate cause?","volume":"68","author":"Coyle","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2012.01.035_b0080","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1176\/ajp.156.10.1646","article-title":"Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia","volume":"156","author":"Adler","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0085","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1300.063","article-title":"Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment","volume":"1003","author":"Laruelle","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mehy.2012.01.035_b0095","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0006-3223(99)00117-1","article-title":"Neurotransmitter interactions in schizophrenia\u2013therapeutic implications","volume":"46","author":"Carlsson","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/0269881105057696","article-title":"Dysregulation of thalamic sensory \u201ctransmission\u201d in schizophrenia: neurochemical vulnerability to hallucinations","volume":"20","author":"Behrendt","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.mehy.2012.01.035_b0105","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0166-2236(00)01817-8","article-title":"Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?","volume":"24","author":"Sharp","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.ajp.162.2.394","article-title":"Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study","volume":"162","author":"Rowland","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0120","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/appi.ajp.2010.09081187","article-title":"The hippocampal formation in schizophrenia","volume":"167","author":"Tamminga","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopsych.2010.04.007","article-title":"A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia","volume":"68","author":"Lisman","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0130","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1523\/JNEUROSCI.21-13-04915.2001","article-title":"Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons","volume":"21","author":"Floresco","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0135","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tins.2008.08.002","article-title":"Limbic and cortical information processing in the nucleus accumbens","volume":"31","author":"Goto","year":"2008","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainresrev.2006.12.008","article-title":"Hippocampal abnormalities and memory deficits: new evidence of a strong pathophysiological link in schizophrenia","volume":"54","author":"Boyer","year":"2007","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.mehy.2012.01.035_b0145","first-page":"371","article-title":"Smoking and schizophrenia","volume":"21","author":"Sagud","year":"2009","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.mehy.2012.01.035_b0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1126\/science.299.5605.333","article-title":"Neuroscience. Deconstructing schizophrenia","volume":"299","author":"Holden","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.01.035_b0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.socscimed.2004.11.057","article-title":"Smoking behavior in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model","volume":"61","author":"Esterberg","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.mehy.2012.01.035_b0160","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.npp.1300466","article-title":"Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients","volume":"29","author":"DeLuca","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.01.035_b0165","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/sj.npp.1300265","article-title":"Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia","volume":"28","author":"Avila","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.01.035_b0170","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.npp.1300450","article-title":"Effects of nicotine on cognitive deficits in schizophrenia","volume":"29","author":"Harris","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.01.035_b0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0893-133X(96)00018-8","article-title":"Nicotine-haloperidol interactions and cognitive performance in schizophrenics","volume":"15","author":"Levin","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.01.035_b0180","first-page":"737","article-title":"A review of the effects of nicotine on schizophrenia","volume":"41","author":"Bidzan","year":"2007","journal-title":"Psychiatr Pol"},{"key":"10.1016\/j.mehy.2012.01.035_b0185","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd2927","article-title":"Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system","volume":"8","author":"Taly","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mehy.2012.01.035_b0190","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/schbul\/sbm083","article-title":"Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia","volume":"33","author":"Buchanan","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.mehy.2012.01.035_b0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.mehy.2012.01.035_b0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0074-7742(06)78008-4","article-title":"Schizophrenia and the alpha7 nicotinic acetylcholine receptor","volume":"78","author":"Martin","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.mehy.2012.01.035_b0205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0891-0618(00)00109-5","article-title":"The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia","volume":"20","author":"Freedman","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.mehy.2012.01.035_b0210","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bcp.2009.05.030","article-title":"TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia","volume":"78","author":"Hauser","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2012.01.035_b0215","first-page":"37","article-title":"Alpha7 nicotinic receptor agonists: potential therapeutic drugs for treatment of cognitive impairments in schizophrenia and alzheimer\u2019s disease","volume":"4","author":"Toyohara","year":"2010","journal-title":"Open Med Chem J"},{"key":"10.1016\/j.mehy.2012.01.035_b0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.schres.2004.12.016","article-title":"Tropisetron improves deficits in auditory P50 suppression in schizophrenia","volume":"76","author":"Koike","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2012.01.035_b0225","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bcp.2009.06.004","article-title":"Nicotinic acetylcholine receptors and the ascending dopamine pathways","volume":"78","author":"Livingstone","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2012.01.035_b0230","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.mehy.2012.01.035_b0235","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/mol.108.046623","article-title":"Presynaptic alpha 7- and beta 2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms","volume":"74","author":"Dickinson","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2012.01.035_b0240","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1460-9568.2008.06077.x","article-title":"Allosteric modulation of alpha 7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission","volume":"27","author":"Arnaiz-Cot","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0245","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-008-1281-x","article-title":"Drug discrimination and neurochemical studies in alpha7 null mutant mice. tests for the role of nicotinic alpha7 receptors in dopamine release","volume":"203","author":"Quarta","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.mehy.2012.01.035_b0250","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1523\/JNEUROSCI.2444-07.2007","article-title":"Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1\/2 and CREB phosphorylation pathways","volume":"27","author":"Bitner","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0255","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0896-6273(00)00042-8","article-title":"Long-term potentiation of excitatory inputs to brain reward areas by nicotine","volume":"27","author":"Mansvelder","year":"2000","journal-title":"Neuron"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2012.01.035_b0260","doi-asserted-by":"crossref","first-page":"S438","DOI":"10.1038\/bjp.2008.5","article-title":"The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology","volume":"153","author":"Maskos","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2012.01.035_b0265","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cne.10138","article-title":"Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons","volume":"444","author":"Azam","year":"2002","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.mehy.2012.01.035_b0270","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X","article-title":"Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization","volume":"425","author":"Quik","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.mehy.2012.01.035_b0275","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.07.005","article-title":"Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes","volume":"78","author":"Sydserff","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2012.01.035_b0280","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"bi-Dargham","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","article-title":"Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence","volume":"41","author":"Carlsson","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.mehy.2012.01.035_b0290","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.0022-3042.2002.00805.x","article-title":"Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals","volume":"80","author":"Marchi","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2012.01.035_b0295","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00966669","article-title":"Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid","volume":"17","author":"Toth","year":"1992","journal-title":"Neurochem Res"},{"key":"10.1016\/j.mehy.2012.01.035_b0300","doi-asserted-by":"crossref","first-page":"28451","DOI":"10.1074\/jbc.M504400200","article-title":"Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: a novel mechanism of gene regulation","volume":"280","author":"Fang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2012.01.035_b0305","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1096-9861(19980803)397:3<371::AID-CNE5>3.0.CO;2-#","article-title":"Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in monkey thalamus","volume":"397","author":"Jones","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.mehy.2012.01.035_b0310","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archpsyc.56.11.1001","article-title":"Gamma frequency-range abnormalities to auditory stimulation in schizophrenia","volume":"56","author":"Kwon","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0315","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1523\/JNEUROSCI.17-02-00576.1997","article-title":"Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus","volume":"17","author":"Lena","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0320","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130050667","article-title":"Nicotinic acetylcholine involvement in cognitive function in animals","volume":"138","author":"Levin","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.mehy.2012.01.035_b0325","series-title":"Frontal-subcortical circuits in psychiatric and neurological disorders","first-page":"372","article-title":"The role of frontal-subcortical circuits in the pathophysiology of schizophrenia","author":"West","year":"2001"},{"key":"10.1016\/j.mehy.2012.01.035_b0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0893-133X(01)00230-5","article-title":"Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release","volume":"25","author":"Balla","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.01.035_b0335","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/oxfordjournals.schbul.a007139","article-title":"Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms","volume":"30","author":"Thompson","year":"2004","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.mehy.2012.01.035_b0340","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-2236(96)10064-3","article-title":"Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs","volume":"20","author":"Grace","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0345","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1523\/JNEUROSCI.18-18-07075.1998","article-title":"Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission","volume":"18","author":"Radcliffe","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.01.035_b0350","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tips.2005.05.007","article-title":"Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance","volume":"26","author":"Buccafusco","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mehy.2012.01.035_b0355","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archpsyc.63.6.630","article-title":"Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia","volume":"63","author":"Olincy","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2012.01.035_b0360","doi-asserted-by":"crossref","first-page":"S522","DOI":"10.1016\/S0924-977X(11)70849-5","article-title":"Effects of alpha7 nicotinic receptor agonist TC-5619 in cognitive dysfunction in schizophrenia","volume":"21","author":"Dunbar","year":"2011","journal-title":"J Neuropsychopharm"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T16:46:40Z","timestamp":1742489200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987712000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0306987712000461"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2012.01.035","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}